Ultragenyx Pharmaceutical Inc. (RARE) Earnings
|
Expand Research on RARE
| Next EPS Date | 7/30/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -22.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$1.23 | N/A | N/A | $181.76M | = | N/A | N/A | ||
| 5/5/26 | Q126 | -$1.84 | -$1.46 | -$0.38 | $136M | $160.69M | = |  | | Details | |
| 4/30/26 |
Q126 | N/A | -$1.46 | N/A | N/A | $160.69M | = | N/A | N/A | ||
| 2/12/26 | Q425 | -$1.29 | -$1.15 | -$0.14 | $207M | $192.15M | = | | | Details | |
| 11/4/25 | Q325 | -$1.81 | -$1.23 | -$0.58 | $160M | $167M | = | | | Details | |
| 8/5/25 |
Q225 | N/A | -$1.30 | N/A | N/A | $161.97M | = | N/A | N/A | ||
| 5/6/25 |
Q125 | N/A | -$1.56 | N/A | $139M | $145.39M | = | N/A | N/A | ||
| 5/1/25 |
Q125 | N/A | -$1.56 | N/A | N/A | $145.39M | = | N/A | N/A |
